Reuters: Regulatory News: US approves Mylan's purchase of Strides unit, with conditions

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

The Best Way to Manage your Money. Start using Mint today to set a budget, track your goals and do more with your money. From our sponsors

US approves Mylan's purchase of Strides unit, with conditions Sep 26th 2013, 22:21 WASHINGTON, Sept 26 | Thu Sep 26, 2013 6:21pm EDT WASHINGTON, Sept 26 (Reuters) - Generic drugmaker Mylan Inc has won U.S. antitrust approval, with conditions, to buy Agila, a unit of India's Strides Arcolab Ltd, the Federal Trade Commission said on Thursday. The companies will have to divest 11 generic injectable drugs as a condition of approving the deal, the FTC said. The deal was valued at $1.6 billion when it was announced in February.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions